PeptiDream. has filed a patent for a guanidine derivative with a low production cost and reduced waste liquor issues. The compound, represented by Formula (I), offers potential pharmaceutical applications. GlobalData’s report on PeptiDream gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on PeptiDream, Cyclosporin derivatives was a key innovation area identified from patents. PeptiDream's grant share as of January 2024 was 17%. Grant share is based on the ratio of number of grants to total number of patents.
A recently filed patent (Publication Number: US20240010627A1) discloses a series of claims related to compounds represented by specific formulas, their tautomers, enantiomers, pharmaceutically acceptable salts, and solvates. The compounds described in the claims have various substituent groups such as hydrogen atoms, halogen atoms, hydroxy groups, amino groups, nitro groups, alkyl groups, alkoxy groups, alkylthio groups, and halogenoalkyl groups. Additionally, the patent outlines methods for manufacturing peptides using the disclosed compounds, involving mixing steps and specific group representations. The patent also covers the manufacture of specific amino acids, their salts, and solvates, providing detailed formulas for each compound.
Furthermore, the patent includes methods for manufacturing peptides using the disclosed compounds, involving specific group representations and manufacturing steps. The amino acids covered in the patent include various complex structures with specific substituent groups and configurations. The disclosed compounds and methods aim to facilitate the production of peptides using the described formulas and processes outlined in the patent. Overall, the patent provides a detailed framework for the synthesis and utilization of specific compounds and amino acids for pharmaceutical applications, emphasizing the importance of precise chemical structures and manufacturing procedures in peptide production.
To know more about GlobalData’s detailed insights on PeptiDream, buy the report here.
See Also:
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
